The benefit varied widely based on individual risk tiers ranging from five fewer deaths in the lowest-risk patients to 48 fewer deaths in the highest-risk groups. ... All articles from the June 11, 2021, ACP Diabetes Monthly Newsletter.
Ultimately, although some uncertainty remains, [this study] provides encouraging evidence of the real-world safety of SGLT-2 inhibitors, allowing patients to benefit from their use with greater confidence in their ... All articles from the August 9, 2019,
Preventive Services Task Force (USPSTF) recently recommended. Based on a systematic review, the USPSTF updated its 2015 recommendation on the subject, lowering the age at which to begin screening from 40 ... All articles from the September 10, 2021, ACP
https://diabetes.acponline.org/archives/2015/08/14/8.htm. ACP has partnered with the American College of Cardiology to participate in the Diabetes Collaborative Registry, a national clinical diabetes registry ... ACP has partnered with the American
stage kidney disease, doubling of creatinine, or death from renal causes) (HR, 0.66; 95% CI, 0.53 to 0.81; P<0.001) with the drug. ... All articles from the May 10, 2019, ACP Diabetes Monthly Newsletter.
Glargine, 300 U/mL (Glar-300), had a favorable weight profile compared with degludec, 100 U/mL (Deg-100); degludec, 200 u/mL (Deg-200); thrice-weekly degludec (Deg-3TW); glargine, ... wrote. All articles from the July 13, 2018, ACP Diabetes Monthly
From 2015 to 2019, the percentage of patients treated with an SGLT2 inhibitor increased from 3.8% to 11.9%. ... All articles from the May 14, 2021, ACP Diabetes Monthly Newsletter.
To update this recommendation, the USPSTF commissioned an evidence review that was published online April 14 by Annals of Internal Medicine and covered in the April 14 ACP Internist Weekly. ... All articles from the November 13, 2015, ACP Diabetes
All articles from the November 14, 2014, ACP Diabetes Monthly Newsletter.
1997 to 2016 among all liveborn singletons from mothers without histories of diabetes or essential hypertension. ... All articles from the April 8, 2022, ACP Diabetes Monthly Newsletter.